Information on Lung Cancer from the Blue Ridge Institute for Medical Research
Lung cancer - also known as bronchogenic carcinoma - is
the most common and yet preventable form of cancer in the United States. What is
the prevention? Don't ever smoke. The National Institutes of Health (NIH) web
site provides an overview of lung cancer- (click here) - with additional information provided by the People Living with
Cancer (PLWC) web site (click here).
The treatments for lung cancer depend upon the stage or progression of the disease at the time of diagnosis. Types or modalities of treatment include surgery, radiation, chemotherapy, and targeted therapy. The following US government web site provides an introduction to this topic: click here.
One of the chief interests of the Blue Ridge Institute for Medical Research is targeted cancer therapy. Targeted therapy is directed against specific proteins or enzymes that are dysregulated and promote cancerous growth. We have studied the actions of (i) Gleevec, which is used in the treatment of chronic myelogenous leukemia, (ii) Tarceva, which is used in the treatment of lung cancer, and (iii) Sutent, which is used in the treatment of kidney cancer and is in clinical trials for the treatment of lung cancer. Information on targeted cancer therapy can be found at the following National Cancer Institute web site: click here.
|Updated 26 December 2007|